Ageing and Parkinson's disease: substantia nigra regional selectivity
about
Executive dysfunction in Parkinson's disease and timing deficitsExercise-induced cognitive plasticity, implications for mild cognitive impairment and Alzheimer's diseaseHigh-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson diseaseIron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processesNetwork structure of brain atrophy in de novo Parkinson's diseaseMapping track density changes in nigrostriatal and extranigral pathways in Parkinson's diseaseMolecular markers of early Parkinson's disease based on gene expression in bloodThe Parkinson disease protein leucine-rich repeat kinase 2 transduces death signals via Fas-associated protein with death domain and caspase-8 in a cellular model of neurodegenerationGlucocerebrosidase is shaking up the synucleinopathiesLocalization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36PGC-1α, a potential therapeutic target for early intervention in Parkinson's diseaseMotor control and aging: links to age-related brain structural, functional, and biochemical effectsAldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson diseaseA Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced deathThe relationship between encephalitis lethargica and influenza: a critical analysisCurrent status of biomarker research in neurologyMouse Genetic Models of Human Brain DisordersΑlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson's DiseaseDifferential effects of dopamine-directed treatments on cognitionMouse models of Parkinson's disease associated with mitochondrial dysfunctionAldehyde Dehydrogenase 1 making molecular inroads into the differential vulnerability of nigrostriatal dopaminergic neuron subtypes in Parkinson's diseaseGlia and alpha-synuclein in neurodegeneration: A complex interactionThe role of free radicals in the aging brain and Parkinson's Disease: convergence and parallelismSolvents and Parkinson disease: a systematic review of toxicological and epidemiological evidenceGene-environment interactions in Parkinson's disease: specific evidence in humans and mammalian modelsAgeing and Parkinson's disease: why is advancing age the biggest risk factor?Early Parkinson's disease symptoms in α-synuclein transgenic monkeys.MAO-B elevation in mouse brain astrocytes results in Parkinson's pathologyEfficient and biologically relevant consensus strategy for Parkinson's disease gene prioritization.Endogenous Parkin Preserves Dopaminergic Substantia Nigral Neurons following Mitochondrial DNA Mutagenic StressColloids as mobile substrates for the implantation and integration of differentiated neurons into the mammalian brainThe transfection of BDNF to dopamine neurons potentiates the effect of dopamine D3 receptor agonist recovering the striatal innervation, dendritic spines and motor behavior in an aged rat model of Parkinson's diseaseGSK-3β dysregulation contributes to parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synucleinLower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotypeNeuroimaging biomarkers of neurodegenerative diseases and dementiaInhibitors of MAO-A and MAO-B in Psychiatry and NeurologyMolecular imaging of movement disordersConverging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's diseaseThe Network Model of Depression as a Basis for New Therapeutic Strategies for Treating Major Depressive Disorder in Parkinson's DiseaseDiversity matters - heterogeneity of dopaminergic neurons in the ventral mesencephalon and its relation to Parkinson's Disease
P2860
Q21090466-FB31B4C2-9169-4C89-882C-94BF83B05365Q21129438-2C24D6F2-F45B-44BC-A00D-3E36002DAD0FQ22065275-EC2A2FC6-66CA-4C17-9B97-6205DFF1D3CBQ22337213-FBD56D06-7CA1-4CC1-A93D-BD8802949ACCQ23890444-BFBB4A32-1A32-4093-9FA9-21CAD810B339Q24040262-A18CFAB6-1B31-481D-8F42-13EF54604C67Q24292810-0255FA04-CCB7-4ADA-8A95-F21C1E74DAEEQ24322927-569CAF04-8416-4647-8D5F-6950E141A26FQ24337392-8518F2F9-7800-478C-9AC4-E4552E64A24AQ24536382-56931F29-773D-4155-B220-EDBE8CD4BE14Q24597726-75FD2532-434E-4220-BDC7-0BE2B230A360Q24628895-78284ECC-DE25-47DA-899E-33BC4EF9CC48Q24632904-04051893-A18E-4BAB-98C2-42434E7E6490Q24644712-B5ACF8CC-43CA-4976-8902-B23CBC90F59CQ24655322-91B75EE6-6C70-412F-944E-788595C12FB2Q26744505-53BDA7FB-AC3D-4CFE-A060-9B549996E92BQ26752246-A7069E8A-9B16-4454-8DCA-1F9BDB74A42AQ26778937-42DA30A7-158D-413C-AFB3-4BFCD548528EQ26801298-BD394ECB-86BC-4C96-A835-253166AC798EQ26829851-1D7EF6E4-6D9D-4FE0-9E8A-FE071C6DAF73Q26850502-AB953396-BD43-4E50-8BAA-B4E42FEB56CAQ26851153-2E4EED5E-0C82-4FE7-9908-5EEA547B1A4EQ26852148-4321261B-5DB0-4C89-8A32-44377F38FB56Q26852462-8E365D4B-C67B-4A56-8C6D-D97F5F4C944BQ26863375-279EC8E7-467E-4DB7-A74A-12E6C9CA4397Q27021628-7D33ED8F-F934-4700-8378-F6559C481BC5Q27301058-D11E8D07-C3EA-43A0-80F6-4578872AD2E4Q27301926-0D44C172-D6B5-4CC1-8514-57A1CCDCEA0EQ27304699-E57306B6-8812-408B-B5B8-AED3A9269403Q27305291-EF91175C-3DB6-4736-A16E-AFDDBD523CD2Q27309969-FE8D9C03-AB47-49D6-8E64-FF0FAF490CA6Q27316252-DC8CF94A-3F3F-4D85-92DF-0C0759DC376AQ27331743-432C6557-7254-4F88-B437-6ACA9F89F596Q27333275-18DAA4AC-5566-4293-A5EA-FE2943C6EC73Q27691820-4616147A-BAD4-46C9-8926-4531AD9E84F7Q28069609-036D3AD1-EC8A-485B-9578-603748823171Q28071336-4A16C353-F521-47B6-9D48-21F880E9CF96Q28074143-F313FC96-C977-4B87-A5B6-7DAE9D4B7E8CQ28078546-ADC2CB16-165D-43E5-9DA8-9FC262377DAAQ28078561-A0611C72-2686-4A5B-A1EF-7C19F81C0B60
P2860
Ageing and Parkinson's disease: substantia nigra regional selectivity
description
1991 nî lūn-bûn
@nan
1991 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Ageing and Parkinson's disease: substantia nigra regional selectivity
@ast
Ageing and Parkinson's disease: substantia nigra regional selectivity
@en
type
label
Ageing and Parkinson's disease: substantia nigra regional selectivity
@ast
Ageing and Parkinson's disease: substantia nigra regional selectivity
@en
prefLabel
Ageing and Parkinson's disease: substantia nigra regional selectivity
@ast
Ageing and Parkinson's disease: substantia nigra regional selectivity
@en
P3181
P356
P1433
P1476
Ageing and Parkinson's disease: substantia nigra regional selectivity
@en
P2093
Fearnley JM
P304
P3181
P356
10.1093/BRAIN/114.5.2283
P407
P478
114 ( Pt 5)
P577
1991-10-01T00:00:00Z